|
ADO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.430200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.948000E-01 |
| Normal-vs-Stage2 |
8.996000E-01 |
| Normal-vs-Stage3 |
8.141800E-01 |
| Normal-vs-Stage4 |
6.876800E-01 |
| Stage1-vs-Stage2 |
9.157000E-01 |
| Stage1-vs-Stage3 |
8.293400E-01 |
| Stage1-vs-Stage4 |
7.420600E-01 |
| Stage2-vs-Stage3 |
9.377200E-01 |
| Stage2-vs-Stage4 |
7.911000E-01 |
| Stage3-vs-Stage4 |
8.492600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.183000E-01 |
| Normal-vs-AfricanAmerican |
6.717400E-01 |
| Normal-vs-Asian |
7.293800E-01 |
| Caucasian-vs-AfricanAmerican |
6.137600E-01 |
| Caucasian-vs-Asian |
7.500600E-01 |
| AfricanAmerican-vs-Asian |
5.759400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.032200E-01 |
| Normal-vs-Female |
9.578400E-02 |
| Male-vs-Female |
3.227700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.969390E-01 |
| Normal-vs-Extreme_Weight |
6.907000E-01 |
| Normal-vs-Obese |
3.883000E-01 |
| Normal-vs-Extreme_Obese |
5.038000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.293600E-01 |
| Normal_Weight-vs-Obese |
7.941800E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.191200E-01 |
| Extreme_Weight-vs-Obese |
3.032800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.263000E-01 |
| Obese-vs-Extreme_Obese |
3.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.929370E-01 |
| Normal-vs-Age(41-60Yrs) |
1.847420E-01 |
| Normal-vs-Age(61-80Yrs) |
3.610200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.658400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.794600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.366250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.962900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.815870E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.809700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.996200E-02 |
| Normal-VS-Type2 PRCC |
4.401200E-03 |
| Normal-VS-KIRP CIMP |
2.154200E-01 |
| Normal-VS-Unclassified PRCC |
9.183400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.02550000000446E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.414400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.815800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.810400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.786200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.273200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.451530E-02 |
| Normal-vs-N1 |
5.529800E-01 |
| Normal-vs-N2 |
3.838800E-01 |
| N0-vs-N1 |
3.371700E-02 |
| N0-vs-N2 |
8.355200E-01 |
| N1-vs-N2 |
2.943800E-01 |
|
|
